Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

MPEP reduces seizure severity in Fmr-1 KO mice over expressing human Abeta.

Westmark CJ, Westmark PR, Malter JS.

Int J Clin Exp Pathol. 2009 Oct 10;3(1):56-68.

2.

Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.

Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK.

Neurology. 2011 Apr 12;76(15):1344-52. doi: 10.1212/WNL.0b013e3182166dc7. Review.

3.

Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid.

Malter JS, Ray BC, Westmark PR, Westmark CJ.

Curr Alzheimer Res. 2010 May;7(3):200-6. Review.

4.

BDNF in fragile X syndrome.

Castrén ML, Castrén E.

Neuropharmacology. 2014 Jan;76 Pt C:729-36. doi: 10.1016/j.neuropharm.2013.05.018. Epub 2013 May 29. Review.

PMID:
23727436
5.

Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.

De Rubeis S, Fernández E, Buzzi A, Di Marino D, Bagni C.

Adv Exp Med Biol. 2012;970:517-51. doi: 10.1007/978-3-7091-0932-8_23. Review.

PMID:
22351071
6.

Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Ronesi JA, Huber KM.

Sci Signal. 2008 Feb 5;1(5):pe6. doi: 10.1126/stke.15pe6. Review.

PMID:
18272470
7.

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Santoro MR, Bray SM, Warren ST.

Annu Rev Pathol. 2012;7:219-45. doi: 10.1146/annurev-pathol-011811-132457. Epub 2011 Oct 10. Review.

PMID:
22017584
8.

Fragile X syndrome: From protein function to therapy.

Bagni C, Oostra BA.

Am J Med Genet A. 2013 Nov;161A(11):2809-21. doi: 10.1002/ajmg.a.36241. Epub 2013 Sep 24. Review.

PMID:
24115651
9.

A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity.

Westmark CJ.

Front Neurol. 2014 Sep 3;5:169. doi: 10.3389/fneur.2014.00169. eCollection 2014. Review.

Supplemental Content

Support Center